People
Matthew Sandiford is a partner in King & Spalding's Finance practice resident in the Atlanta office. Matthew is active in King & Spalding's leveraged finance, healthcare, venture finance and specialty finance practices.
Matthew represents financial institutions, lenders, investors, borrowers, underwriters and arrangers in leveraged finance, securitization and other secured and unsecured lending transactions, with a focus on healthcare services, pharmaceuticals, franchisors, medical device and sponsor finance transactions.
Matthew holds a Bachelor of Science in Foreign Service from Georgetown University and a J.D. from the University of Virginia. Matthew was a Robert Bosch Foundation Fellowship in Germany, during which he worked at the European Central Bank and Hamburg Commercial Bank.
King & Spalding brings together more than 100 finance lawyers located in offices across the United States, Europe, Asia and the Middle East to represent lenders, investors, funds and borrowers in the full range of secured and unsecured financings. Over the past three years, we closed approximately 600 finance transactions for our clients, amounting to $165 billion in aggregate financing.
J.D., University of Virginia
B.S., Georgetown University
Georgia
New York
German
Spanish
June 13, 2025
K&S advises ThreatQuotient in its acquisition by Securonix
June 11, 2025
King & Spalding Earns Top-Tier Rankings in Legal 500 United States 2025 Guide
June 11, 2025
King & Spalding Advised ThreatQuotient in Its Acquisition by Securonix
Borrowers and lenders in venture debt financing of emerging technology and life science companies.
Financial institutions in leveraged buyout, dividend recapitalization, debtor-in-possession and other financing transactions.
Arrangers and underwriters in securitization of numerous asset classes.
June 13, 2025
K&S advises ThreatQuotient in its acquisition by Securonix
June 11, 2025
King & Spalding Earns Top-Tier Rankings in Legal 500 United States 2025 Guide
June 11, 2025
King & Spalding Advised ThreatQuotient in Its Acquisition by Securonix
Borrowers and lenders in venture debt financing of emerging technology and life science companies.
Financial institutions in leveraged buyout, dividend recapitalization, debtor-in-possession and other financing transactions.
Arrangers and underwriters in securitization of numerous asset classes.
June 13, 2025
K&S advises ThreatQuotient in its acquisition by Securonix
June 11, 2025
King & Spalding Earns Top-Tier Rankings in Legal 500 United States 2025 Guide
June 11, 2025
King & Spalding Advised ThreatQuotient in Its Acquisition by Securonix
J.D., University of Virginia
B.S., Georgetown University
Georgia
New York
German
Spanish